Atorvastatin (Dispitor (20 mg)) is an HMG-CoA reductase inhibitor, also known as "statin”, prescribed for hyperlipidemia. The information provided on this page is intended to serve as a comprehensive ...

The Atorvastatin and Amlodipine in Patients With Elevated Lipids and Hypertension (AVALON) study has demonstrated that amlodipine 5 mg administered once daily in combination with atorvastatin 10 mg is ...

LIPTRUZET (ezetimibe and atorvastatin) tablets The FDA has approved Liptruzet, combination of ezetimibe and atorvastatin, for the treatment of elevated LDL cholesterol in patients with primary or ...

Ezetimibe/simvastatin: 10/10 mg, 10/20 mg, 10/40 mg, and 10/80 mg. Atorvastatin: 10 mg, 20 mg, 40 mg, and 80 mg. The primary end point of the study was the percent change from baseline to the end of ...

Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...

Ranbaxy Laboratories Limited (Ranbaxy) announced that the company has launched the generic versions of Atorvastatin tablets, 10mg, 20 mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in ...

Ranbaxy has issued a voluntary recall for 41 batches of its generic version of Atorvastatin Calcium (Lipitor; Pfizer), with the full knowledge of the FDA. The voluntary recall, which includes 10mg, ...

The Gemini-AALA study was a 14-week, real-world, prospective, titration-to-goal, non-comparative, open-label trial conducted at 123 centres across 27 countries in the Middle East/Africa (Israel, ...

Ranbaxy, the often-troubled manufacturer of generic drugs, will temporarily stop manufacturing generic atorvastatin. On November 9, 2012 the company announced a voluntary recall of some lots of ...